Key facts
- Lhotse Medical’s last known valuation is $10.0M (Dec 2023).
- It has raised $3.7M across 1 recorded rounds; the latest was Seed Round ($2.2M) in Dec 2023.
- Notable investors include Cadence Healthcare Ventures.
- Lhotse Medical has filed 1 Form D with the SEC, most recently Jan 2024 ($2.2M sold to 7 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Lhotse Medical
Funding rounds
1 roundsAbout Lhotse Medical
Developer of a healthcare software platform designed to enhance patient care through advanced technology. The company offers products and services that streamline medical processes and improve healthcare outcomes, enabling healthcare providers to deliver efficient and effective care.
- Sector
- Healthcare
- HQ
- Oakland, CA, United States
- Founded
- 2021
- Employees
- 50
- Ownership
- Privately Held (backing)
Lhotse Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lhotse Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lhotse Medical in its N-PORT filings yet. We sweep new filings monthly.